首页|期刊导航|化学试剂|新型三氮唑酰胺衍生物的设计、合成及其抗真菌活性研究

新型三氮唑酰胺衍生物的设计、合成及其抗真菌活性研究OA

Design,Synthesis,and Antifungal Activity of Novel Triazole Amide Derivatives

中文摘要英文摘要

三唑类药物是目前临床上治疗侵袭性真菌感染最广泛的药物,但耐药现象日益严重,给真菌感染的治疗带来严峻挑战.为了寻找结构新颖、抗真菌活性优异的广谱抗真菌药物,合成一系列新型三氮唑酰胺衍生物,并研究其抗真菌活性.以(2S)-2-(4-异丁基苯基)丙酸、(2S)-2-(6-甲氧基萘-2-基)丙酸、(S)-1-Boc-2-甲基哌嗪和 1-Boc-哌嗪为起始原料,设计并合成了 4 个三唑酰胺衍生物,其结构经 1HNMR、13 CNMR 和 MS 确证.通过体外活性测试方法评价此类化合物对白色念珠菌、烟曲霉、新型隐球菌和氟康唑耐药白色念珠菌的抑制作用.实验结果显示,三唑酰胺衍生物具有良好的抗真菌和抗耐药真菌活性.其中,(2S)-1-[(3S)-4-[(2R,3R)-3-(2,4-二氟苯基)-3-羟基-4-(1,2,4-三氮杂环戊熳-1-基)丁-2-基]-3-甲基哌嗪-1-基]-2-[4-(2-甲基丙基)苯基]丙-1-酮(3e)是最有效的抗真菌药物,对白色念珠菌、新型隐球菌和烟曲霉这 3 种最常见和最关键的致病真菌的 MIC80值分别为 0.25、2.0 和 2.0 μg/mL.此外,化合物 3e 还对氟康唑耐药白色念珠菌表现出强效活性.分子对接模拟了化合物 3e 与白色念珠菌 CYP51 蛋白的结合模式,分析了化合物与靶酶形成相互作用的关键氨基酸残基.该类化合物具有较强的体外抗真菌活性,值得进一步探索和研究.

Triazoles are currently the most widely used drugs for treating invasive fungal infections in clinical practice.However,drug resistance is becoming increasingly serious,posing challenges for the treatment of fungal infections.To discover antifungal agents with novel structures and excellent broad-spectrum antifungal activity,a series of new triazole amide derivatives were synthesized and evaluated for their antifungal activity.Four novel triazole amide derivatives were designed and synthesized by utilizing(2S)-2-(4-isobutylphenyl)propanoic acid,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,(S)-1-Boc-2-methylpiperazine,and 1-Boc-piperazine as starting materials.The structures of the triazole amide derivatives were characterized by 1 HNMR,13 CNMR and MS.Subsequently,their inhibitory effects on Candida albicans,Aspergillus fumigatus,Cryptococcus neoformans,and azole-resistant Candida were assessed through in vitro assays.The triazole amide derivatives demonstrated excellent antifungal and anti-drug-resistant fungal activities.Among them,(2S)-1-[(3S)-4-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazapentadien-1-yl)but-2-yl]-3-methylpiperazine-1-yl]-2-[4-(2-methylpropyl)phenyl]propan-1-one(3e)was the most potent antifungal agent with MIC80 values of 0.25,2.0,and 2.0 μg/mL against Candida albicans,Cryptococcus neoformans,and Aspergillus fumigatus,respectively,which are the three most common and critical priority pathogenic fungi.Compound 3e also exhibited potent activity against azole-resistant Candida.Molecular docking was used to simulate the binding mode of compound 3e with Candida albicans CYP51 and to analyze the potential amino acid residues involved in the formation of interactions between each compound and the target enzyme.These compounds have strong in vitro antifungal activity and are worthy of further exploration and research.

朱盼虎;胡伯羽;杨文谦

暨南大学 药学院,广东 广州 511400广州一品红制药有限公司,广东 广州 510760广州一品红制药有限公司,广东 广州 510760

化学化工

抗真菌对接设计合成三氮唑体外

antifungaldockingdesign and synthesistriazolevitro

《化学试剂》 2026 (4)

20-25,6

10.13822/j.cnki.hxsj.2026.0029

评论